Ticker League

Boston Scientific (BSX) Free Cash Flow Bridge

Pinpoint what moved Boston Scientific's FCF from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

TTM

FCF YoY

+19.81%

OCF YoY

+13.88%

Capex YoY

-4.26%

FCF Conversion Δ

+3.9 pp

Free cash flow bridge for Boston Scientific (BSX) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $569M

FCF bridge breakdown for Boston Scientific (BSX) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$2.87B
  • Operating Cash Flow$529M
  • Capital Expenditure$40M
  • Free Cash Flow$3.44B
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation